Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Small Cell Lung Carcinoma × Chloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Gliosarcoma 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

Carboplatin 19 Etoposide 17 Cisplatin 14 Topotecan 9 pembrolizumab 8 atezolizumab 6 Pemetrexed 6 Nivolumab 6 Radiosurgery 5 Irinotecan 5 Paclitaxel 4 rovalpituzumab tesirine 3 durvalumab 3 Radiotherapy 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Cyclophosphamide 3 Albumin-Bound Paclitaxel 3 vistusertib 2 pelcitoclax 2 etoposide phosphate 2 epacadostat 2 Vorinostat 2 Radiation 2 Gemcitabine 2 Fluorodeoxyglucose F18 2 Docetaxel 2 vorolanib 1 venetoclax 1 trioctyl phosphine oxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01575782 2017-07-18

Chloroquine

Maastricht Radiation Oncology

Phase 1 Terminated

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡